Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Zacks Investment Research on MSN
Vertex Plunges Around 24% in Six Months: How to Play the Stock
Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...
Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...
Our lab data proves you can find top-performing cordless vacuums with long-lasting batteries and strong suction without breaking the bank.
At this grand event focusing on the deep integration of technology and innovation, Xu Yihan, Senior Executive Vice President ...
In May, a group of about 40 people stood in a circle deep within the Pyramid of Khafre, the second-largest of the three pyramids looming over Egypt’s Giza Plateau, holding hands and praying for Earth.
Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...
The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.
NYT Wordle Today: What began as a small puzzle game by software engineer Josh Wardle in 2021 has become a global sensation. The New York Times acquired Wordle in 2022, cementing its place in the daily ...
Ethan Krieger (He/Him) is an editor at DualShockers that got started in the writing industry by covering professional basketball for a sports network. Despite being a diehard sports fan (mainly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results